Skip to main content

Inflammatory Bowel Disease

A research team studied whether normalizing levels of fecal calprotectin can reduce the risk of progression of Crohn disease and if a treat-to-target algorithm can make a difference.
Dr Cohen reviews his presentation from the July 25 AIBD regional meeting on using biosimilars as first-line and switch therapy in patients with inflammatory bowel disease.
Miguel Regueiro, MD, reviewed how COVID-19 has affected the practice of gastroenterology and the role of telemedicine in negotiating the pandemic at the Advances in Inflammatory Bowel Diseases 2020 virtual regional meeting on July 25.
He discusses his presentation at the virtual Advances in Inflammatory Bowel Disease 2020 regional meeting July 25 on preparing patients with IBD for surgery.
Russell Cohen, MD, reviews his presentation from the virtual AIBD regional meeting July 25 on defining the target to treat in inflammatory bowel disease.
Back to Top